IncFact
Company Profiles: Revenue, Growth, Competition

INTERPACE DIAGNOSTICS GROUP Revenue, Growth & Competitor Profile

DBA Interpace Diagnostics
DBA PDI, INC.
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Interpace Diagnostics Group

Access the complete profile.

Interpace Diagnostics Group Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes42421
AddressMorris Corporate Center 1 Building C, 300 Interpace Parkway
Parsippany, NJ 07054

www.pdi-inc.com


Interpace Diagnostics Group's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry.


Interpace Diagnostics Group's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Interpace Diagnostics Group is a publicly traded company on NCM using the ticker symbol IDXG. Detailed information on company financials and operating reports can be found here: NCM: IDXG



Interpace Diagnostics Group Annual Revenue and Growth Rate

Interpace Diagnostics Group Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Interpace Diagnostics Group's revenues are gauged from an analysis of company filings.



Investor Activity

Interpace Diagnostics Group has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
January 27, 2020 2 100%$47 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Interpace Diagnostics Group is developing and marketing. Interpace Diagnostics Group's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
SERACOV
Diagnostic testing of bodily fluids for use in antibody detection, namely, for identifying antibodies that neutralize the COVID-19 virus in patient blood samples
05/08/2020
COVIANT
Diagnostic testing of bodily fluids for use in antibody detection, namely, for identifying antibodies that neutralize the COVID-19 virus in patient blood samples
05/08/2020
INTERPACE PHARMA SOLUTIONS
laboratory services for pharmaceutical development
11/05/2019

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Interpace Diagnostics Group grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Interpace Diagnostics Group is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Drugs & Druggists' Sundries Merchant Wholesalers

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Interpace Diagnostics Group's Largest Competitors

A competitive analysis shows these companies are in the same general field as Interpace Diagnostics Group, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
AMERISOURCEBERGEN DRUGValley Forge, PA100 
CARDINAL HEALTHDublin, OH81 
MCKESSONIrving, TX30 
OWENS & MINOR DISTRIBUTIONMechanicsville, VA4 
CATALENT PHARMA SOLUTIONSSomerset, NJ3 
TAKEDA PHARMACEUTICALS AMERICADeerfield, IL3 
HIKMA PHARMACEUTICALS USAEatontown, NJ2 
EUROPA SPORTS PRODUCTS LLC.Charlotte, NC1 
J M SMITHSpartanburg, SC1 




Nearby Competitors

These companies are similar in business line and location to Interpace Diagnostics Group. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
FERRING PHARMACEUTICALSParsippany, NJ100 
WOCKHARDT HOLDINGSParsippany, NJ21 
INTERPACE DIAGNOSTICS GROUPParsippany, NJ20 
OCTAPHARMA USAHoboken, NJ13 
MEDIMETRIKS PHARMACEUTICALSFairfield, NJ5 
RICOLA USAParsippany, NJ3 




Future Competition: Interpace Diagnostics Group's Fastest Growing Competitors

These companies are in the same general field as Interpace Diagnostics Group and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Interpace Diagnostics Group Competitors